Lyra Therapeutics
LYRA
LYRA
31 hedge funds and large institutions have $38.1M invested in Lyra Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less capital invested
Capital invested by funds: $59.9M → $38.1M (-$21.8M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
31
Holding in Top 10
–
Calls
$9K
Puts
$1K
Top Buyers
| 1 | +$120K | |
| 2 | +$23.4K | |
| 3 | +$21.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.03K |
Top Sellers
| 1 | -$322K | |
| 2 | -$123K | |
| 3 | -$42.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$35.8K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$11.6K |